NO994440D0 - FremgangsmÕte ved pÕvisning av tidlig magekreft - Google Patents

FremgangsmÕte ved pÕvisning av tidlig magekreft

Info

Publication number
NO994440D0
NO994440D0 NO994440A NO994440A NO994440D0 NO 994440 D0 NO994440 D0 NO 994440D0 NO 994440 A NO994440 A NO 994440A NO 994440 A NO994440 A NO 994440A NO 994440 D0 NO994440 D0 NO 994440D0
Authority
NO
Norway
Prior art keywords
gastric cancer
cox
procedure
detection
early gastric
Prior art date
Application number
NO994440A
Other languages
English (en)
Other versions
NO994440L (no
Inventor
Ari Ristimoki
Matti Horkoenen
Pentti Sipponen
Original Assignee
Locus Genex Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Locus Genex Oy filed Critical Locus Genex Oy
Publication of NO994440D0 publication Critical patent/NO994440D0/no
Publication of NO994440L publication Critical patent/NO994440L/no

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6841In situ hybridisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57446Specifically defined cancers of stomach or intestine
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
NO994440A 1997-03-18 1999-09-13 Fremgangsmåte ved påvisning av tidlig magekreft NO994440L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI971124A FI971124A0 (fi) 1997-03-18 1997-03-18 Metod foer diagnostisering av magcancer
PCT/FI1998/000238 WO1998041864A1 (en) 1997-03-18 1998-03-18 Diagnosis of early gastric cancer

Publications (2)

Publication Number Publication Date
NO994440D0 true NO994440D0 (no) 1999-09-13
NO994440L NO994440L (no) 1999-11-18

Family

ID=8548414

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994440A NO994440L (no) 1997-03-18 1999-09-13 Fremgangsmåte ved påvisning av tidlig magekreft

Country Status (20)

Country Link
US (1) US6416961B1 (no)
EP (1) EP0968421B1 (no)
JP (1) JP2001519900A (no)
KR (1) KR20000076291A (no)
CN (1) CN1250523A (no)
AT (1) ATE272838T1 (no)
AU (1) AU732228B2 (no)
BR (1) BR9808378A (no)
CA (1) CA2284048A1 (no)
DE (1) DE69825431T2 (no)
DK (1) DK0968421T3 (no)
ES (1) ES2226105T3 (no)
FI (1) FI971124A0 (no)
IL (1) IL131594A (no)
NO (1) NO994440L (no)
NZ (1) NZ338068A (no)
PT (1) PT968421E (no)
RU (1) RU2204835C2 (no)
TR (1) TR199902298T2 (no)
WO (1) WO1998041864A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6335193B1 (en) * 1999-04-15 2002-01-01 Padmanabhan P Nair Isolated colonocytes
WO2001051660A2 (en) * 2000-01-14 2001-07-19 Vera Genics Ltd. Method and kit for diagnosis of neoplastic transformation
CA2404428A1 (en) 2000-03-27 2001-10-04 Thomas Jefferson University High specificity marker detection
AU2001251223A1 (en) * 2000-03-30 2001-10-15 Diadexus, Inc. Compositions and methods for diagnosing, monitoring, staging, imaging and treating stomach cancer
CA2451483C (en) * 2001-06-25 2011-02-15 Oncomedx, Inc. Methods for detecting and monitoring cox-2 rna in plasma and serum
AU2002359817A1 (en) * 2001-12-21 2003-07-30 Diadexus, Inc. Compositions and methods relating to gastric specific genes and proteins
KR100475642B1 (ko) * 2001-12-29 2005-03-10 한국생명공학연구원 암 발생 및 전이에 관여하는 단백질의 당쇄 변화를측정하여 암을 진단하는 방법 및 이를 이용한 진단킷트
AU2003280991A1 (en) * 2002-07-10 2004-02-02 Japan As Represented By The President Of The University Of Tokyo Method for diagnosis of intestinal-type gastric tumors
CA2503517A1 (en) * 2002-10-25 2004-05-06 Oncotherapy Science, Inc. Method for diagnosing diffuse-type gastric cancer
NZ588323A (en) * 2003-07-17 2012-04-27 Pacific Edge Biotechnology Ltd Markers for the detection of gastric cancer
US20050014165A1 (en) * 2003-07-18 2005-01-20 California Pacific Medical Center Biomarker panel for colorectal cancer
US20050075543A1 (en) * 2003-10-03 2005-04-07 Calabrese Charles A. Method of anonymous medical testing and providing the patient with the test results
KR100645979B1 (ko) * 2004-08-09 2006-11-15 한국생명공학연구원 위암 유전자 마커 및 이를 이용한 위암 진단킷트
US20080032943A1 (en) * 2005-11-04 2008-02-07 Johji Inazawa Method for detecting cancer and a method for suppressing cancer
RU2613139C1 (ru) * 2015-10-12 2017-03-15 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ дифференциальной диагностики рака желудка различных гистологических типов
RU2613300C1 (ru) * 2015-11-10 2017-03-15 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ диагностики низко дифференцированного нейроэндокринного рака желудка
RU2642989C1 (ru) * 2016-12-19 2018-01-29 федеральное государственное автономное образовательное учреждение высшего образования "Санкт-Петербургский политехнический университет Петра Великого" (ФГАОУ ВО "СПбПУ") Способ диагностики онкологических заболеваний
CN109387635A (zh) * 2018-11-07 2019-02-26 国家纳米科学中心 基于热泳细胞外囊泡检测的胃癌检测系统及方法
RU2743221C1 (ru) * 2020-10-12 2021-02-16 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Петрова" Министерства здравоохранения Российской Федерации Способ определения типа рака желудка по классификации lauren методом компьютерной томографии

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459239A (en) 1994-01-24 1995-10-17 Merck Frosst Canada Inc. Peptide sequences and antipeptide antisera for detecting human cyclooxygenase-1 and cyclooxygenase-2 proteins

Also Published As

Publication number Publication date
RU2204835C2 (ru) 2003-05-20
CN1250523A (zh) 2000-04-12
PT968421E (pt) 2004-10-29
IL131594A0 (en) 2001-01-28
DE69825431D1 (de) 2004-09-09
CA2284048A1 (en) 1998-09-24
EP0968421B1 (en) 2004-08-04
TR199902298T2 (xx) 2000-01-21
NZ338068A (en) 2001-03-30
US6416961B1 (en) 2002-07-09
DK0968421T3 (da) 2004-12-06
EP0968421A1 (en) 2000-01-05
FI971124A0 (fi) 1997-03-18
NO994440L (no) 1999-11-18
AU6404198A (en) 1998-10-12
ATE272838T1 (de) 2004-08-15
IL131594A (en) 2004-02-19
JP2001519900A (ja) 2001-10-23
BR9808378A (pt) 2000-05-23
AU732228B2 (en) 2001-04-12
DE69825431T2 (de) 2005-07-28
WO1998041864A1 (en) 1998-09-24
KR20000076291A (ko) 2000-12-26
ES2226105T3 (es) 2005-03-16

Similar Documents

Publication Publication Date Title
NO994440D0 (no) FremgangsmÕte ved pÕvisning av tidlig magekreft
DK0667920T3 (da) Fremgangsmåder til påvisning af prostatacancermetastase
CA2072314A1 (en) Methods for detection of carcinoma metastases by nucleic acid amplification
DK0988534T3 (da) Elektroniske fremgangsmåder og apparat til detektering af analytter
WO2001018252A3 (en) Methods for disease detection
ATE376187T1 (de) Nachweis von erkrankungen der nieren und behandlung
WO2000056352A3 (en) Reagents and methods useful for detecting diseases of the prostate
ATE419516T1 (de) Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc)
WO2003001183A3 (en) Methods for detecting and monitoring cox-2 rna in plasma and serum
WO2004084804A3 (en) Detection and monitoring of lung cancer
WO2001063293A3 (en) Diagnosis and treatment of schizophrenia
WO2001004343A3 (en) A method for determining the prognosis of cancer patients by measuring levels of bag expression
Rogalsky et al. Electrophoretic characteristics of macro creatine kinase type 2 in serum.
WO2001002828A3 (en) Diagnosis of cancer by detecting ash2 polypeptides or polynucleotides
WO1998021365A3 (en) Method for detection of metastatic prostate cancer
FI961678A (fi) Alukkeita ja koettimia CMV:n nukleiinihapon monistamiseksi ja havaitsemiseksi
WO2001065262A3 (en) Reagents and methods useful for detecting diseases of the breast
AU2001285157A1 (en) 5t4 rna in plasma and serum as a marker for neoplastic disease
CN108548922B (zh) 检测yap k342甲基化修饰的试剂及其应用
WO2000060119A3 (en) Methods for detecting cancer cells
Shioya et al. Determination in plasma of angiotensin-converting enzyme inhibitor by inhibitor-binding assay
WO2002081656A3 (en) Enhanced diagnostic potential of prostate-specific antigen expressing cells
EP1438326A4 (en) DIAGNOSIS, TREATMENT AND PREVENTION OF CANCER THROUGH PROTEIN CABLES
WO2000041516A3 (en) Reagents and methods useful for detecting diseases of the breast
DE60126088D1 (de) Wechselwirkung zwischen tbx2 und dem arf-promoter in zellzyklus-regulator-assays

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application